Cargando…

Corrigendum to “Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2” [Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864/6 2019 941-956]

Detalles Bibliográficos
Autores principales: Nikolaou, Aikaterini, Kokotou, Maroula G., Vasilakaki, Sofia, Kokotos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445307/
https://www.ncbi.nlm.nih.gov/pubmed/31221540
http://dx.doi.org/10.1016/j.bbalip.2019.06.009
_version_ 1784568626141986816
author Nikolaou, Aikaterini
Kokotou, Maroula G.
Vasilakaki, Sofia
Kokotos, George
author_facet Nikolaou, Aikaterini
Kokotou, Maroula G.
Vasilakaki, Sofia
Kokotos, George
author_sort Nikolaou, Aikaterini
collection PubMed
description
format Online
Article
Text
id pubmed-8445307
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-84453072021-09-16 Corrigendum to “Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2” [Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864/6 2019 941-956] Nikolaou, Aikaterini Kokotou, Maroula G. Vasilakaki, Sofia Kokotos, George Biochim Biophys Acta Mol Cell Biol Lipids Corrigendum Elsevier B.V. 2019-11 2019-06-17 /pmc/articles/PMC8445307/ /pubmed/31221540 http://dx.doi.org/10.1016/j.bbalip.2019.06.009 Text en © 2018 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Corrigendum
Nikolaou, Aikaterini
Kokotou, Maroula G.
Vasilakaki, Sofia
Kokotos, George
Corrigendum to “Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2” [Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864/6 2019 941-956]
title Corrigendum to “Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2” [Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864/6 2019 941-956]
title_full Corrigendum to “Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2” [Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864/6 2019 941-956]
title_fullStr Corrigendum to “Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2” [Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864/6 2019 941-956]
title_full_unstemmed Corrigendum to “Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2” [Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864/6 2019 941-956]
title_short Corrigendum to “Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2” [Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864/6 2019 941-956]
title_sort corrigendum to “small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases a2” [biochim. biophys. acta mol. cell biol. lipids 1864/6 2019 941-956]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445307/
https://www.ncbi.nlm.nih.gov/pubmed/31221540
http://dx.doi.org/10.1016/j.bbalip.2019.06.009
work_keys_str_mv AT nikolaouaikaterini corrigendumtosmallmoleculeinhibitorsaspotentialtherapeuticsandastoolstounderstandtheroleofphospholipasesa2biochimbiophysactamolcellbiollipids186462019941956
AT kokotoumaroulag corrigendumtosmallmoleculeinhibitorsaspotentialtherapeuticsandastoolstounderstandtheroleofphospholipasesa2biochimbiophysactamolcellbiollipids186462019941956
AT vasilakakisofia corrigendumtosmallmoleculeinhibitorsaspotentialtherapeuticsandastoolstounderstandtheroleofphospholipasesa2biochimbiophysactamolcellbiollipids186462019941956
AT kokotosgeorge corrigendumtosmallmoleculeinhibitorsaspotentialtherapeuticsandastoolstounderstandtheroleofphospholipasesa2biochimbiophysactamolcellbiollipids186462019941956